Get the Stockscreener App
19.99
3.12%
0.605
After Hours:
20.15
0.16
+0.80%
Adma Biologics Inc stock is traded at $19.99, with a volume of 4.40M.
It is up +3.12% in the last 24 hours and up +15.48% over the past month.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
See More
Previous Close:
$19.39
Open:
$19.285
24h Volume:
4.40M
Relative Volume:
0.98
Market Cap:
$4.62B
Revenue:
$330.24M
Net Income/Loss:
$34.79M
P/E Ratio:
-99.95
EPS:
-0.2
Net Cash Flow:
$66.12M
1W Performance:
-0.20%
1M Performance:
+15.48%
6M Performance:
+202.88%
1Y Performance:
+458.38%
1-Day Range:
$19.27
$20.37
1-Week Range:
$19.07
$20.37
52-Week Range:
$3.06
$20.37
Adma Biologics Inc Stock (ADMA) Company Profile
Name
Adma Biologics Inc
Sector
Industry
Phone
(201) 478-5552
Address
C/O ADMA BIOLOGICS, INC., RAMSEY
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Resumed | Raymond James | Strong Buy |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Nov-11-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-09-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-04-19 | Initiated | Jefferies | Buy |
| Apr-15-19 | Reiterated | H.C. Wainwright | Buy |
| Feb-07-19 | Resumed | H.C. Wainwright | Buy |
| Dec-11-17 | Reiterated | Maxim Group | Buy |
| Nov-14-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-23-17 | Upgrade | Maxim Group | Hold → Buy |
| Aug-01-16 | Downgrade | Maxim Group | Buy → Hold |
| Jul-25-16 | Reiterated | Maxim Group | Buy |
| May-13-15 | Reiterated | Maxim Group | Buy |
| Dec-08-14 | Initiated | Oppenheimer | Outperform |
| Dec-01-14 | Reiterated | Maxim Group | Buy |
View All
Adma Biologics Inc Stock (ADMA) Latest News
Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Perceptive Advisors LLC Has $30.98 Million Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Bank of Montreal Can Purchases New Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Driehaus Capital Management LLC Acquires 447,743 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Up 30.7% in September - MarketBeat
D. E. Shaw & Co. Inc. Buys 1,442,799 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Is ADMA Biologics Inc. (ADMA) the Best Performing Small-Cap Stock in 2024? - Yahoo Finance
Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Alpha DNA Investment Management LLC Has $450,000 Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
10 Best Performing Small-Cap Stocks in 2024 - Insider Monkey
AlTi Global Inc. Sells 61,310 Shares of Archer-Daniels-Midland Company (NYSE:ADM) - Defense World
Stocks of Adaptimmune Therapeutics Plc ADR (ADAP) are poised to climb above their peers - SETE News
Check out these key findings about Adma Biologics Inc (ADMA) - SETE News
Summit Trail Advisors LLC Purchases Shares of 4,154 Archer-Daniels-Midland Company (NYSE:ADM) - Defense World
A new trading data show Applied Dna Sciences Inc (APDN) is showing positive returns. - SETE News
Was there any good news for Adaptive Biotechnologies Corp (ADPT) stock in the last session? - US Post News
Amdocs Limited (NASDAQ:DOX) Shares Sold by Inspire Investing LLC - Defense World
Adaptive Biotechnologies Corp (ADPT) gets rating Resumed from JP Morgan - Knox Daily
ADEA’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Biomarker Data from Oncology Trial for Adicet Bio’s Game Delta T-cell Therapy ADI-001 Indicates Potential for Use in Autoimmune Disease - CGTLive™
Adaptimmune Therapeutics Plc ADR [ADAP] Piccina Cintia sells 24,531 Shares for $22814.0 - Knox Daily
(ADXN) Long Term Investment Analysis - Stock Traders Daily
1832 Asset Management L.P. Buys 451,700 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Marshall Wace LLP Acquires 531,597 Shares of Analog Devices, Inc. (NASDAQ:ADI) - Defense World
ADMA Biologics (NASDAQ:ADMA) Shares Down 3.2% - MarketBeat
Advanced Micro Devices (NASDAQ:AMD) Shares Down 1% - MarketBeat
AdaptHealth Target of Unusually High Options Trading (NASDAQ:AHCO) - Defense World
Predicting Adma Biologics Inc’s (ADMA) earnings for the current quarter - US Post News
Analog Devices, Inc. (NASDAQ:ADI) Gets Downgrade - FXDailyReport.com
Daily Progress: Adaptive Biotechnologies Corp (ADPT) Drop -8.39, Closing at 4.26 - The Dwinnex
ADTX’s Stochastic Averages Dip: Analyzing Aditxt Inc’s Stock Performance - The InvestChronicle
Distillate Capital Partners LLC Buys Shares of 178,661 Amdocs Limited (NASDAQ:DOX) - Defense World
Gabelli Funds LLC Has $14.87 Million Holdings in Archer-Daniels-Midland Company (NYSE:ADM) - Defense World
Applied Dna Sciences Inc (APDN) Stock: A Year of Market Fluctuations - The InvestChronicle
The ADPT Stock Puzzle: Unraveling Adaptive Biotechnologies Corp’s Fluctuating Performance - The InvestChronicle
Adma Biologics Inc [ADMA] Insider Guiheen Lawrence P. sells 9,000 Shares - Knox Daily
Archer-Daniels-Midland Company (NYSE:ADM) Shares Acquired by Xponance Inc. - MarketBeat
(ADMA) On The My Stocks Page - Stock Traders Daily
14:30 Rights Issue: Penny Stock Under Rs 5 To Keep Under Radar As Company Signs Mou With Leading Agri‐Product FMCG Company, Aiming To Expand Into Diverse Industries Ahead - Dalal Street Investment Journal
Analysts’ Weekly Ratings Changes for Adicet Bio (ACET) - Defense World
AMD Stock Surged 6% Yesterday. Here's Why. - Nasdaq
Market Watch: Applied Dna Sciences Inc (APDN)’s Noteworthy Gain, Closing at 1.25 - The Dwinnex
ADAP’s price-to-sales ratio: Is it a good investment opportunity? - US Post News
Ratios Uncovered: Breaking Down Adaptimmune Therapeutics Plc ADR (ADAP)’s Trailing Twelve Months Metrics - The Dwinnex
Understanding ADTX’s financial ratios: A beginner’s guide - US Post News
Market Highlights: Aditxt Inc (ADTX) Ends on a Low Note at 0.38 - The Dwinnex
Altshuler Shaham Ltd Raises Stake in Amdocs Limited (NASDAQ:DOX) - Defense World
Demystifying Addus HomeCare: Insights From 8 Analyst Reviews - Benzinga
Applied Dna Sciences Inc (APDN) presents a great opportunity, but the stock is slightly overvalued - US Post News
Adriatic Metals operational update 'encouraging' says broker, shares rise - Proactive Investors UK
Magnetar Financial LLC Sells 947,120 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Adma Biologics Inc Stock (ADMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):